CD147 receptor is essential for TFF3-mediated signaling regulating colorectal cancer progression
Hong‐Yong Cui(National Medical Products Administration), Zhi‐Nan Chen(National Medical Products Administration), Gang Nan(Air Force Medical University), Fen-Ling Liu(Air Force Medical University), Jian‐Li Jiang(Air Force Medical University), Huijie Bian(Air Force Medical University), Xu Cheng(Tianjin University of Traditional Chinese Medicine), Yu Zhao(Dali University), Bin Wu(East China University of Science and Technology), Xi Chen(Jilin Province Science and Technology Department), Yang Zhang(Peking University), Bin Wang(Wuhan University), Shijie Wang(Air Force Medical University), Ling Li(Shihezi University), Ting Guo(Air Force Medical University), Jing Xu(State Key Laboratory of Cancer Biology), Yumeng Zhu(Sichuan University), Fei Song(Institute of Cancer Research), Hai Zhang(Air Force Medical University), Xiangmin Yang(National Medical Products Administration), Xiuxuan Sun(Air Force Medical University), Meirui Qian(Air Force Medical University), Jiayue Li(Northwest A&F University), Ruo-Fei Tian(Air Force Medical University)
Cited by 81
Related Papers
Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
|Cell Metabolism|2020|1.7k
CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells
|Signal Transduction and Targeted Therapy|2020|1.2k
Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in China
|Hepatology|2020|448
<i>TBX6</i> Null Variants and a Common Hypomorphic Allele in Congenital Scoliosis
|New England Journal of Medicine|2015|317